Thyroglobulin Antibodies Blood Test Results Explained

Κατηγορίες
Άρθρα
Υγεία του θυρεοειδούς Ερμηνεία εργαστηριακών αποτελεσμάτων Ενημέρωση 2026 Φιλικό προς τον ασθενή

A positive TgAb result can point toward autoimmune thyroid disease, but it can also complicate thyroid cancer follow-up by making thyroglobulin harder to trust. That is why this test needs context, not guesswork.

📖 ~10-12 λεπτά 📅
📝 Δημοσιεύτηκε: 🩺 Ιατρικά ελέγχθηκε: ✅ Με βάση τα διαθέσιμα επιστημονικά δεδομένα
⚡ Σύντομη Σύνοψη v1.0 —
  1. Τιμή αναφοράς Many labs report TgAb as negative below about 4 IU/mL, but some assays use cutoffs closer to 1 or 20 IU/mL.
  2. Autoimmune clue Positive TgAb supports autoimmune thyroid disease when paired with abnormal TSH, free T4, or TPO antibodies.
  3. Cancer follow-up TgAb can make serum thyroglobulin look falsely low or undetectable after thyroid cancer treatment.
  4. Μετράει η τάση Falling TgAb over 6-24 months after thyroidectomy is usually reassuring; a persistent rise deserves review.
  5. Not a severity score A TgAb of 200 IU/mL does not automatically mean worse symptoms than 20 IU/mL.
  6. Καλύτερες συνοδευτικές εξετάσεις TSH, free T4, TPOAb, and sometimes ultrasound give the clearest blood test interpretation.
  7. Χρόνος επανεξέτασης Stable patients often recheck in 6-12 months; thyroid cancer follow-up may be every 3-12 months.
  8. Επείπτωτα συμπτώματα New neck mass, hoarseness lasting more than 2-3 weeks, trouble swallowing, or severe palpitations need prompt medical review.

What the thyroglobulin antibodies blood test actually measures

Ο thyroglobulin antibodies blood test detects immune proteins that target θυρεοσφαιρίνη, the storage protein inside thyroid follicles. A positive result most often supports autoimmune thyroid disease and, after thyroid cancer treatment, can distort follow-up by interfering with thyroglobulin measurement; on Καντέστι Τεχνητή Νοημοσύνη we flag that distinction immediately, and our οδηγό για την εξέταση θυρεοειδούς shows where TgAb fits.

Clinical view of thyroid antibody testing with thyroid model and serum sample
Σχήμα 1: Thyroglobulin antibodies target protein stored inside thyroid follicles.

The test measures antibodies, not thyroid hormone, and not the thyroglobulin protein itself. That sounds obvious, but in real clinic work we regularly see patients mix up TgAb με θυρεοσφαιρίνη, even though one is an immune marker and the other is often used as a tumor marker after thyroid cancer treatment.

A typical scenario is a patient with fatigue, constipation, and a TSH of 6.8 mIU/L whose report also shows TgAb at 118 IU/mL. When Dr. Thomas Klein reviews a panel like that, the antibody result does not stand alone; we look at the hormone pattern, the symptoms, the medication list, and whether there is any thyroid surgery history.

As of May 17, 2026, this remains one of the most misunderstood thyroid markers online. The practical takeaway is simple: a positive TgAb result often says more about immune activity around the thyroid than about how severe your symptoms are today, and it definitely does not work as a general cancer screening test.

Why patients confuse TgAb with thyroglobulin

Thyroglobulin antibodies are immune proteins, while θυρεοσφαιρίνη is a thyroid-made protein. In blood test results explained well, those two markers are separated because TgAb can distort thyroglobulin follow-up, especially after thyroid cancer treatment.

What counts as normal, borderline, or positive

A normal TgAb result depends on the assay, not on one universal global cutoff. Many labs report negative below about 4 IU/mL, borderline from 4-9 IU/mL, and positive at 10 IU/mL or higher, but some methods use reference limits closer to 1 IU/mL ή 20 IU/mL.

3D molecular view of antibodies surrounding thyroglobulin inside a thyroid follicle
Σχήμα 2: Assay cutoffs vary because labs measure different antibody patterns.

Here is what matters for blood test interpretation: use the reference range printed by your own lab. If your result is 6 IU/mL, that may be mildly positive in one laboratory and still negative in another; our article on οι τιμές εργαστηρίου σε διαφορετικές μονάδες explains why thyroid markers can look surprisingly different across reports.

A higher number does δεν reliably equal more thyroid damage. We see patients with TgAb above 200 IU/mL who still have normal TSH and free T4, and we also see patients with TgAb around 15 IU/mL who already have clear hypothyroidism.

Borderline results deserve caution, not drama. A change from 4.2 to 5.1 IU/mL is often less meaningful than a persistent rise on repeat testing done with the same assay and interpreted beside TSH, free T4, symptoms, and prior results.

Negative/Within Range Often <4 IU/mL, but assay-specific Usually no measurable TgAb by that method; autoimmune thyroid disease is less likely but not excluded.
Διαχωριστική γραμμή Often 4-9 IU/mL May reflect low-level antibody activity or normal assay noise; repeat only if the clinical picture supports it.
Θετικός Often 10-100 IU/mL Supports autoimmune thyroid disease when paired with abnormal TSH, free T4, TPOAb, or ultrasound findings.
Markedly Positive Συχνά >100 IU/mL Strong immune signal, but still not a severity score and not an emergency by itself.

Why the same IU/mL number can mean different things

Antibody assays do not all detect the same antibody population with the same sensitivity. Some European labs use lower cutoffs, some hospital labs use broader reference intervals, and that is exactly why a printed flag alone does not answer the question of what does my blood test mean.

Can TgAb also appear in Graves disease or postpartum thyroiditis

Ναί, TgAb can be positive in Graves disease, postpartum thyroiditis, and silent thyroiditis. The antibody is not exclusive to Hashimoto's, which is one reason good blood test interpretation always uses the whole thyroid panel.

Anatomical thyroid context illustration showing diffuse gland enlargement in the neck
Σχήμα 4: TgAb can appear in several autoimmune thyroid conditions, not just Hashimoto's.

Σε νόσος Graves, the antibody that matters most for diagnosis is usually TRAb ή TSI, but TgAb may also be present. When our team sees suppressed TSH below 0.1 mIU/L, υψηλό ελεύθερο T4, and positive TgAb, we do not call it Hashimoto's by reflex; we step back and ask whether the broader pattern fits Graves, thyroiditis, or a transition state, and our Graves versus hypothyroid guide walks through that difference.

Postpartum thyroiditis often appears within 12 months after delivery and can move through a hyperthyroid phase, a hypothyroid phase, or both. The 2017 American Thyroid Association pregnancy and postpartum guideline notes that thyroid antibody positivity increases postpartum thyroid risk (Alexander et al., 2017); if symptoms began after birth, our new mothers lab guide can help frame the next steps.

The thing is, timing changes meaning. A woman who is 4 months postpartum with palpitations, a TSH of 0.03 mIU/L, and positive TgAb needs a very different discussion from a 52-year-old with gradual weight gain and TSH of 7.2 mIU/L, even if both share the same antibody flag.

Why doctors pair TgAb with TSH, free T4, TPOAb, and ultrasound

TgAb alone is incomplete. The clearest answer usually comes from combining TSH, ελεύθερη T4, αντισώματα TPO, symptoms, and sometimes thyroid ultrasound when the gland feels enlarged or a nodule is suspected.

Laboratory still life of thyroid assay tubes and ultrasound probe
Σχήμα 5: A full thyroid workup is more useful than any single antibody.

Most adult labs use a TSH reference range around 0.4-4.0 mIU/L, although age, pregnancy, and local method matter. Our οδηγός για το εύρος του TSH και free T4 interpretation article show why a normal hormone on one visit does not always settle the question if symptoms are strong or antibodies persist.

TPOAb is often the more sensitive autoimmune marker, but TgAb adds useful detail when the picture is borderline. The reason we worry about positive TPOAb plus positive TgAb more than TgAb alone is that together they increase the odds that ongoing autoimmune thyroid disease is real rather than incidental.

Ultrasound becomes helpful when there is a palpable lump, neck asymmetry, or concern for nodules. A thyroid nodule of 1 cm or larger often triggers structured ultrasound risk assessment, and ultrasound can also show the heterogeneous echo pattern that clinicians commonly associate with chronic autoimmune thyroiditis.

Why one lab's positive result can be another lab's negative

Assay design, calibration, and antibody heterogeneity can make TgAb results vary meaningfully between laboratories. That is why repeating the test at a different lab can create apparent change even when your thyroid status has barely moved.

Portrait of a chemiluminescent immunoassay analyzer used for thyroid antibody testing
Σχήμα 6: Method differences are a major reason thyroid antibody results shift.

Different immunoassays recognize different antibody targets and use different calibration standards. If you want a deeper look at this problem, our pieces on η διακύμανση των εξετάσεων αίματος και πώς να διαβάσετε τα αποτελέσματα των εξετάσεων αίματος explain why a flagged value is sometimes about methodology as much as biology.

Pre-analytic issues matter too, though less dramatically than with some hormone tests. High-dose πριν από εξετάσεις θυρεοειδούς ή ορμονικές ανοσοπροσδιοριστικές εξετάσεις, νηστέψτε, often sold in 5.000-10.000 mcg capsules, more commonly distorts TSH και ελεύθερη T4 than TgAb, but it still belongs on the medication list; our οδηγός για βιοτίνη και εξετάσεις θυρεοειδούς covers that trap.

Here is the practical tip I give patients: if you are trending TgAb over time, use the ίδιο εργαστήριο whenever possible. A smaller number from a new lab may not be improvement, and a higher number from a new lab may not be deterioration.

Why TgAb matters after thyroid cancer treatment

Μετά thyroid cancer surgery, TgAb matters because it can make θυρεοσφαιρίνη look falsely low or even undetectable on common immunometric assays. That is a big deal, because thyroglobulin is often used as a follow-up marker after treatment for differentiated thyroid cancer.

Molecular illustration of antibodies masking thyroglobulin in a lab assay
Σχήμα 7: Antibodies can interfere with thyroglobulin tumor-marker follow-up.

In patients who had a total thyroidectomy, often with radioactive iodine as well, clinicians usually want unstimulated thyroglobulin to be very low. According to the American Thyroid Association cancer guideline (Haugen et al., 2016), interpretation depends on the assay and risk setting, but a highly sensitive test showing Tg below 0.2 ng/mL is often reassuring only when interference is not present; our post-thyroidectomy thyroid test guide explains the broader follow-up picture.

This is one of those areas where context matters more than the number. If Tg is undetectable but TgAb is positive and rising, the apparently comforting thyroglobulin result may be misleading rather than reassuring.

Dr. Thomas Klein has seen this exact confusion in follow-up clinics: a patient is told their tumor marker is fine, yet the antibody trend has been climbing for a year. Rising TgAb does not prove recurrence, but it is enough to justify a more careful review of imaging, pathology risk, and the follow-up schedule.

When a positive result does not mean you are sick

A positive TgAb result does not automatically mean active disease, severe disease, or cancer. Mild positivity can show up before hormone changes appear, and some people remain euthyroid for years.

Comparison of thyroid follicles with mild antibody activity versus active autoimmune damage
Σχήμα 9: Antibody positivity and current thyroid dysfunction are not always the same thing.

This is where many internet explanations go wrong. A mildly positive antibody can reflect risk, history, ή immune tendency rather than a current need for treatment, which is why our article on γιατί τα φυσιολογικά εύρη μπορεί να παραπλανήσουν is so relevant to what does my blood test mean.

Positive TgAb by itself does δεν diagnose thyroid cancer. In fact, outside the post-cancer follow-up setting, the antibody is much more often connected to autoimmune thyroid disease than to malignancy.

I see this pattern in family screening quite a bit. A patient with normal TSH, normal free T4, and TgAb of 18 IU/mL may simply need repeat testing in 6-12 months, especially if symptoms are minimal and examination is otherwise unremarkable.

When to repeat the test and what changes over time

Stable patients with isolated TgAb positivity often repeat testing in 6-12 μήνες. Patients with thyroid cancer follow-up, recent thyroiditis, pregnancy-related changes, or shifting TSH may need a shorter interval such as 3-6 μήνες.

Macro view of serial serum samples arranged to represent repeat thyroid testing
Σχήμα 10: Repeat timing matters because antibody movement is usually gradual, not daily.

If the main question is autoimmune thyroid disease, repeat timing usually depends on TSH, ελεύθερη T4, and symptoms rather than on the antibody alone. Our guide on when to repeat abnormal lab work gives a broader framework that fits thyroid testing well.

Antibodies tend to change more slowly than hormones. If levothyroxine is started or adjusted, TSH is often rechecked in about 6-8 weeks, while TgAb may drift over months; our article on TSH timelines after starting levothyroxine explains why those clocks are different.

Pregnancy and the postpartum period deserve extra nuance. A person who is antibody-positive and develops new symptoms after delivery may need testing sooner than the usual annual plan, especially if TSH swings from suppressed to elevated over a few months.

Symptoms and patient scenarios that justify a fuller thyroid panel

Fatigue, cold intolerance, weight change, constipation, hair shedding, palpitations, tremor, neck fullness, and unexplained menstrual or postpartum changes can justify a broader thyroid workup. TgAb is most useful when it answers a real clinical question, not when it is ordered in isolation.

Documentary scene of a patient touching the neck while reviewing thyroid-related symptoms
Σχήμα 11: Symptoms give thyroid antibodies their real clinical meaning.

Ένας ασθενής με κόπωση, dry skin, constipation, και ένα TSH of 8.1 mIU/L is very different from a patient who feels well and only has TgAb of 12 IU/mL. If you are sorting through unexplained low energy, our οδηγός εργαστηριακών εξετάσεων για την κόπωση helps identify when thyroid testing belongs on the short list.

Cold intolerance is another classic clue, but not a thyroid-specific one. That is why we often compare thyroid results with iron and B12 markers, and our cold intolerance testing guide shows how those patterns overlap.

There is another angle here: symptoms of excess thyroid hormone matter too. Palpitations, anxiety, heat intolerance, and weight loss with positive TgAb can still point to νόσος Graves or thyroiditis rather than hypothyroidism, especially when το TSH είναι κάτω από 0.1 mIU/L.

What to do after a positive thyroglobulin antibodies blood test

The next step after a positive TgAb result is usually confirmation of thyroid status, not panic. Most patients need a structured review of TSH, ελεύθερη T4, symptoms, medications, and sometimes ultrasound rather than an immediate treatment decision.

Overhead view of selenium-rich foods beside thyroid medication and a serum sample
Σχήμα 12: After a positive result, targeted next steps beat random supplement buying.

If hormones are normal and symptoms are mild, watchful follow-up is often appropriate. If TSH is high, free T4 is low, or the thyroid feels enlarged, the conversation changes and treatment or imaging becomes more likely.

Medication and supplement review matters more than many people realize. Adults need about 55 mcg of selenium per day, while chronic intake above 400 mcg per day can be harmful, so I generally prefer food-first strategies and careful dosing; our selenium and thyroid guide is a sensible place to start.

Do not chase the antibody number alone. We worry less about whether TgAb is 60 or 160 IU/mL than about whether TSH is drifting upward, whether free T4 is falling, whether symptoms are accumulating, and whether there is any thyroid cancer history in the chart.

How Kantesti AI interprets these results in context

Kantesti AI does not read TgAb in isolation. Our engine checks the assay range, matched thyroid hormones, medication clues, trend direction, and whether the report looks more like autoimmune thyroid disease or thyroid cancer follow-up; you can see the workflow on η πλατφόρμα μας για ανάλυση αίματος με AI.

3D physiological pathway linking pituitary, thyroid, thyroglobulin, and antibody interference
Σχήμα 13: Contextual interpretation works best when antibodies are tied to the whole pathway.

Kantesti AI compares the reported TgAb value with TSH, ελεύθερη T4, TPOAb, and previous thyroid panels before generating blood test results explained in plain language. We also highlight method and safety limitations, and our η σελίδα ιατρικής επικύρωσης explains how we handle clinical standards and uncertainty.

Σε όλο 2+ εκατομμύρια χρήστες σε 127+ χώρες και 75+ γλώσσες, we consistently see the same confusion: people are told an antibody is high but not told whether that matters now, later, or mainly in cancer follow-up. That is why our PDF and photo workflow matters; the οδηγός για μεταφόρτωση PDF εξετάσεων αίματος shows how our platform reads the whole report in about 60 δευτερόλεπτα instead of one isolated line item.

Thomas Klein, MD, reviews thyroid content with our physician team, and the doctors behind our models are listed on the Ιατρική Συμβουλευτική Επιτροπή. When we mention a thyroid antibody signal, we also state what would increase concern, what would lower concern, and when a human clinician should step in.

We also publish our methodology. For readers who want the technical side, the κλινική μελέτη επικύρωσης gives a research-level view of how Kantesti evaluates lab interpretation quality across large international datasets.

When you should seek prompt medical review

TgAb positivity alone is rarely urgent, but certain symptoms are. Prompt medical review is warranted for a new neck mass, progressive hoarseness lasting more than 2-3 weeks, trouble swallowing, resting heart rate above 120, severe shortness of breath, confusion, or marked drowsiness with swelling and cold intolerance.

Watercolor anatomical thyroid illustration highlighting pressure symptoms and nearby airway structures
Σχήμα 14: Urgency comes from symptoms and pattern, not from the antibody alone.

After thyroid cancer treatment, rising TgAb plus a new lump, persistent cough, or voice change deserves faster follow-up than a quiet antibody rise on an otherwise stable report. In autoimmune disease, urgent review is more often driven by thyrotoxicosis symptoms, severe hypothyroid symptoms, or pregnancy-related context than by the antibody number itself.

If your results are confusing and your appointment is still days away, you can upload them to our δωρεάν demo ερμηνείας εξετάσεων αίματος for structured, patient-friendly context. And if something in the report or your symptoms needs escalation, use Επικοινωνήστε μαζί μας so the right team can point you to the safest next step.

Συμπέρασμα: thyroglobulin antibodies are a context marker. They matter a lot in autoimmune thyroid disease, and they matter differently after thyroid cancer, but the result becomes genuinely useful only when it is interpreted beside hormones, symptoms, history, and trends.

Συχνές Ερωτήσεις

What is a normal thyroglobulin antibody level?

A normal thyroglobulin antibody level depends on the assay, but many laboratories report TgAb as negative below about 4 IU/mL. Some methods use lower or higher cutoffs, such as less than 1 IU/mL or less than 20 IU/mL, so the printed lab range matters more than a generic internet number. A borderline result just above the cutoff is often less informative than the overall pattern with TSH, free T4, and repeat testing in the same lab.

Does a positive TgAb result mean I have Hashimoto's?

A positive TgAb result increases the likelihood of autoimmune thyroid disease, but it does not diagnose Hashimoto's by itself. The diagnosis becomes stronger when TSH is elevated, free T4 is low or low-normal, TPO antibodies are also positive, or ultrasound shows a typical heterogeneous thyroid pattern. Some people have positive TgAb for months or years while TSH remains in the reference range, so treatment decisions should not be based on the antibody alone.

Can thyroglobulin antibodies mean thyroid cancer?

Positive thyroglobulin antibodies do not usually mean thyroid cancer. In most general outpatient settings, TgAb is far more closely linked to autoimmune thyroid disease than to malignancy. The cancer-related issue is different: after thyroid cancer treatment, TgAb can interfere with thyroglobulin measurement and make a tumor-marker result look falsely low, which is why trend interpretation matters.

Why are thyroglobulin antibodies checked after thyroidectomy for cancer?

After thyroidectomy for differentiated thyroid cancer, clinicians often follow serum thyroglobulin as a marker of remaining thyroid tissue. TgAb is checked because positive antibodies can interfere with common immunometric thyroglobulin assays and make thyroglobulin appear undetectable even when residual tissue is present. A falling TgAb trend over 6-24 months is usually more reassuring than a stable or rising trend, especially when measured by the same laboratory method.

How often should a positive TgAb result be repeated?

For stable patients without major symptoms, repeat testing is often done in 6-12 months. If TSH is changing, if thyroid symptoms are increasing, if the patient is postpartum, or if thyroid cancer follow-up is involved, repeat testing may happen sooner, sometimes every 3-6 months. The most useful comparison comes from using the same laboratory and reading TgAb together with TSH, free T4, and clinical history.

Can thyroglobulin antibodies go back down?

Yes, thyroglobulin antibodies can fall over time. In autoimmune thyroid disease they may drift downward slowly, stay positive for years, or fluctuate with immune activity, while after thyroidectomy for thyroid cancer they often decline over 1-3 years if little thyroid tissue remains. A falling number is usually more meaningful than a single low reading, and a persistent rise is the pattern that deserves closer review.

Λάβετε σήμερα ανάλυση εξετάσεων αίματος με AI

Εγγραφείτε σε πάνω από 2 εκατομμύρια χρήστες παγκοσμίως που εμπιστεύονται το Kantesti για άμεση, ακριβή ανάλυση εργαστηριακών εξετάσεων. Ανεβάστε τα αποτελέσματα εξετάσεων αίματος και λάβετε ολοκληρωμένη ερμηνεία βιοδεικτών του 15,000+ μέσα σε δευτερόλεπτα.

📚 Παραπομπές σε δημοσιεύσεις έρευνας

1

Klein, T., Mitchell, S., & Weber, H. (2026). Πολύγλωσση AI με Υποστήριξη Κλινικής Απόφασης για Πρώιμο Τριαζ Αποκλεισμού του Ιού της Χανταβίρωσης: Σχεδιασμός, Μηχανική Επικύρωση και Πραγματική Ανάπτυξη σε 50.000 Ερμηνευμένες Αναφορές Εξετάσεων Αίματος. Ιατρική έρευνα του Kantesti με AI.

2

Klein, T., Mitchell, S., & Weber, H. (2026). Οδηγός Πρωτεϊνών Ορού: Εξέταση Αίματος Σφαιρινών, Αλβουμίνης και Αναλογίας A/G. Ιατρική έρευνα του Kantesti με AI.

📖 Εξωτερικές ιατρικές αναφορές

3

Θυρεοειδίτιδα Hashimoto: Κλινικά και διαγνωστικά κριτήρια. . Autoimmunity Reviews..Οδηγός ασθενούς για την ερμηνεία εργαστηριακών εξετάσεων 2026 Ενημέρωση Οι ήπια μη φυσιολογικοί αριθμοί που έχουν ελεγχθεί από κλινικό ιατρό είναι συνηθισμένοι, αλλά ο χρόνος της...

4

Haugen BR κ.ά. (2016). 2015 Αμερικανικές Κατευθυντήριες Οδηγίες της Αμερικανικής Εταιρείας Θυρεοειδούς για τη διαχείριση ενηλίκων ασθενών με όζους θυρεοειδούς και διαφοροποιημένο καρκίνο του θυρεοειδούς. Thyroid.

5

Alexander EK et al. (2017). Κατευθυντήριες Οδηγίες του 2017 της Αμερικανικής Εταιρείας Θυρεοειδούς για τη διάγνωση και τη διαχείριση της νόσου του θυρεοειδούς κατά την εγκυμοσύνη και μετά τον τοκετό. Thyroid.

2+ εκατομμύριαΑναλυθείσες δοκιμές
127+χωρών
98.4%Ακρίβεια
75+Γλώσσες

⚕️ Ιατρική αποποίηση ευθύνης

Σήματα εμπιστοσύνης E-E-A-T

Εμπειρία

Κλινική ανασκόπηση από ιατρό για τις ροές εργασίας ερμηνείας εργαστηριακών αποτελεσμάτων.

📋

Πραγματογνωμοσύνη

Εστίαση στην εργαστηριακή ιατρική στο πώς συμπεριφέρονται οι βιοδείκτες στο κλινικό πλαίσιο.

👤

Αυθεντικότητα

Γραμμένο από τον Δρ. Thomas Klein με ανασκόπηση από την Δρ. Sarah Mitchell και τον Καθ. Dr. Hans Weber.

🛡️

Αξιοπιστία

Ερμηνεία βασισμένη σε τεκμηριωμένα δεδομένα με σαφείς οδούς παρακολούθησης για τη μείωση του συναγερμού.

🏢 Καντέστι ΕΠΕ Εγγεγραμμένη στην Αγγλία & Ουαλία · Αρ. Εταιρείας. 17090423 Λονδίνο, Ηνωμένο Βασίλειο · kantesti.net
blank
Από Prof. Dr. Thomas Klein

Ο Δρ. Thomas Klein είναι πιστοποιημένος κλινικός αιματολόγος, ο οποίος υπηρετεί ως Ιατρικός Διευθυντής στην Kantesti AI. Με πάνω από 15 χρόνια εμπειρίας στην εργαστηριακή ιατρική και βαθιά εξειδίκευση στη διαγνωστική με τη βοήθεια της Τεχνητής Νοημοσύνης, ο Δρ. Klein γεφυρώνει το χάσμα μεταξύ της τεχνολογίας αιχμής και της κλινικής πρακτικής. Η έρευνά του επικεντρώνεται στην ανάλυση βιοδεικτών, στα συστήματα υποστήριξης κλινικών αποφάσεων και στη βελτιστοποίηση του εύρους αναφοράς ανά πληθυσμό. Ως CMO, ηγείται των τριπλά τυφλών μελετών επικύρωσης που διασφαλίζουν ότι η Τεχνητή Νοημοσύνη της Kantesti επιτυγχάνει ακρίβεια 98,7% σε πάνω από 1 εκατομμύριο επικυρωμένες περιπτώσεις δοκιμών από 197 χώρες.

Αφήστε μια απάντηση

Η ηλ. διεύθυνση σας δεν δημοσιεύεται. Τα υποχρεωτικά πεδία σημειώνονται με *